Daclatasvir Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Daclatasvir is used along with another medication (sofosbuvir [Solvadi]) to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors.Daclatasvir Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Daclatasvir Nitroso CAS NO:NA chemically represented as Methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1-nitroso-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate. Synchemia is the leading manufacturing and exporter of Daclatasvir Nitroso . We supply Daclatasvir Nitroso with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142115 |
| CAS No | NA |
| Mol.F. | C20H20Cl2N2O5 |
| Mol.Wt. | 439.29 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142116 |
| CAS No | NA |
| Mol.F. | C16H12Cl2N2O6 |
| Mol.Wt. | 399.18 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142117 |
| CAS No | NA |
| Mol.F. | C9H8N2O4 |
| Mol.Wt. | 208.17 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142118 |
| CAS No | NA |
| Mol.F. | C9H9ClN2O2 |
| Mol.Wt. | 212.63 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142119 |
| CAS No | NA |
| Mol.F. | C5H8N2O4S |
| Mol.Wt. | 192.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142120 |
| CAS No | NA |
| Mol.F. | C10H14N4O8S2 |
| Mol.Wt. | 382.36 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142121 |
| CAS No | NA |
| Mol.F. | C7H10N2O5S |
| Mol.Wt. | 234.23.g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142122 |
| CAS No | NA |
| Mol.F. | C9H18N2O5S |
| Mol.Wt. | 266.31 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142123 |
| CAS No | NA |
| Mol.F. | C5H8N2O6S |
| Mol.Wt. | 224.19 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142124 |
| CAS No | NA |
| Mol.F. | C8H12N2O5S |
| Mol.Wt. | 248.25 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142125 |
| CAS No | NA |
| Mol.F. | C5H8N2O4S |
| Mol.Wt. | 192.19 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142126 |
| CAS No | NA |
| Mol.F. | C8H13N3O6S2 |
| Mol.Wt. | 311.33 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142127 |
| CAS No | NA |
| Mol.F. | C5H4N6O2 |
| Mol.Wt. | 180.13 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142128 |
| CAS No | NA |
| Mol.F. | C9H12N6O5 |
| Mol.Wt. | 284.23 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142129 |
| CAS No | NA |
| Mol.F. | C18H23N5O6S |
| Mol.Wt. | 437.47 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142130 |
| CAS No | NA |
| Mol.F. | C17H21N5O6S |
| Mol.Wt. | 423.44 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |